BDNF and Parkinson disease: Our proposed protocol aims at investigate whether HF-rTMS treatment for 4 weeks, targeting the right and left DLPFC, can increase plasma BDNF and plasmatic EV-derived BDNF concentration and improve EFs in PD patients.